DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 03 · Volume 85 · 2001 DOI: 10.1055/s-007-35808

Commentary

375
Key, Nigel S.; Bach, Ronald R.: Tissue Factor as a Therapeutic Target
377
Bauer, Kenneth A.: Conventional Fibrinolytic Assays for the Evaluation of Patients with Venous Thrombosis: Don’t Bother

Rapid Communications

379
Presta, Leonard; Sims, Paul; Meng, Y. Gloria; Moran, Paul; Bullens, Sherron; Bunting, Stuart; Schoenfeld, Jill; Lowe, David; Lai, Jadine; Rancatore, Patricia; Iverson, Mark; Lim, Amy; Chisholm, Vanessa; Kelley, Robert F.; Riederer, Markus; Kirchhofer, Daniel: Generation of a Humanized, High Affinity Anti-tissue Factor Antibody for Use as a Novel Antithrombotic Therapeutic
390
Crowther, Mark A.; Roberts, Jeremy; Roberts, Robin; Johnston, Marilyn; Stevens, Pamela; Skingley, Peter; Patrassi, G. M.; Sartori, M. T.; Hirsh, Jack; Prandoni, Paolo; Weitz, Jeffrey I.; Gent, Michael; Ginsberg, Jeffrey S.: Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study

Review Article

395
Bennett, Joel S.; Mousa, Shaker: Platelet Function Inhibitors in the Year 2000
401
Storey, Robert F.; Oldroyd, Keith G.; Wilcox, Robert G.; the Investigators; on behalf of: Open Multicentre Study of the P2T Receptor Antagonist AR-C69931MX Assessing Safety, Tolerability and Activity in Patients with Acute Coronary Syndromes
408
Warner, Darren; Mansfield, Michael W.; Grant, Peter J.: Coagulation Factor XIII and Cardiovascular Disease in UK Asian Patients Undergoing Coronary Angiography
412
Simó, Josep M.; Joven, Jorge; Vilella, Elisabet; Ribas, Montserrat; Pujana, Miguel A.; Sundaram, Indirana M.; Hammel, Jeffrey P.; Hoover-Plow, Jane L.: Impact of Apolipoprotein(a) Isoform Size Heterogeneity on the Lysine Binding Function of Lipoprotein(a) in Early Onset Coronary Artery Disease
418
Pengo, Vittorio; Legnani, Cristina; Noventa, Franco; Palareti, Gualtiero; the ISCOAT; on behalf of: Oral Anticoagulant Therapy in Patients with Nonrheumatic Atrial Fibrillation and Risk of Bleeding
430
Bernstein, Charles N.; Blanchard, James F.; Houston, Donald S.; Wajda, Andre: The Incidence of Deep Venous Thrombosis and Pulmonary Embolism among Patients with Inflammatory Bowel Disease: A Population-based Cohort Study
435
Sheth, S.B.; DiCicco, R.A.; Hursting, M.J.; Montague, T.; Jorkasky, D.K.: Interpreting the International Normalized Ratio (INR) in Individuals Receiving Argatroban and Warfarin
445
Russell, K. E.; Read, M. S.; Bellinger, D. A.; Leitermann, K.; Rup, B. J.; McCarthy, K. P.; Keith, J. C.; Khor, S. P.; Schaub, R. G.; Nichols, T. C.: Intratracheal Administration of Recombinant Human Factor IX (BeneFix™) Achieves Therapeutic Levels in Hemophilia B Dogs
450
Brennan, Stephen O.; Wyatt, Jane M.; May, Stephen; De Caigney, Susan; George, Peter M.: Hypofibrinogenemia due to Novel 316 Asp → Tyr Substitution in the Fibrinogen Bβ Chain
454
Oldenburg, J.; Kriz, K.; Wuillemin, W. A.; Maly, F. E.; von Felten, A.; Siegemund, A.; Keeling, D. M.; Baker, P.; Chu, K.; Konkle, B. A.; Lämmle, B.; Albert, T.; the Study Group on Hereditary Warfarin Sensitivity: Genetic Predisposition to Bleeding during Oral Anticoagulant Therapy: Evidence for Common Founder Mutations (FIXVal-10 and FIXThr-10) and an Independent CpG Hotspot Mutation (FIXThr-10)
458
Iakhiaev, Alexei; Ruf, Wolfram; Rao, Vijaya Mohan L.: The Role of Catalytic Cleft and Exosite Residues of Factor VIIa for Complex Formation with Tissue Factor Pathway Inhibitor
464
Lee, Soo Young; Chang, Sung Keun; Lee, Il Ha; Kim, Yu-Mie; Chung, Soo Il: Depletion of Plasma Factor XIII Prevents Disseminated Intravascular Coagulation-induced Organ Damage
470
Meh, David A.; Siebenlist, Kevin R.; Brennan, Stephen O.; Holyst, Trudy; Mosesson, Michael W.: The Amino Acid Sequence in Fibrin Responsible for High Affinity Thrombin Binding
475
Himber, Jacques; Refino, Canio J.; Burcklen, Louis; Roux, Sébastien; Kirchhofer, Daniel: Inhibition of Arterial Thrombosis by a Soluble Tissue Factor Mutant and Active Site-blocked Factors IXa and Xa in the Guinea Pig
482
Schick, Barbara P.; Gradowski, Joel F.; San Antonio, James D.; Martinez, Jose: Novel Design of Peptides to Reverse the Anticoagulant Activities of Heparin and other Glycosaminoglycans
488
Markou, Christos P.; Chronos, Nicolas A. F; Hanson, Stephen R.: Antithrombotic Effects of Ionic and Non-ionic Contrast Media in Nonhuman Primates
494
Gerner, Christopher; Steinkellner, Werner; Holzmann, Klaus; Gsur, Andrea; Grimm, Rudolf; Ensinger, Christian; Obrist, Peter; Sauermann, Georg: Elevated Plasma Levels of Crosslinked Fibrinogen Gamma-chain Dimer Indicate Cancer-related Fibrin Deposition and Fibrinolysis
502
Lee, Agnes Y. Y.; Fredenburgh, James C.; Stewart, Ronald J.; Rischke, Janice A.; Weitz, Jeffrey I.: Like Fibrin, (DD)E, the Major Degradation Product of Crosslinked Fibrin, Protects Plasmin from Inhibition by α2-antiplasmin
509
Briedé, Jacob J.; Heemskerk, Johan W. M.; Cornelis van’t, Veer; Hemker, H. Coenraad; Lindhout, Theo: Contribution of Platelet-derived Factor Va to Thrombin Generation on Immobilized Collagen- and Fibrinogen-adherent Platelets
514
Missy, K.; Plantavid, M.; Pacaud, P.; Viala, C.; Chap, H.; Payrastre, B.: Rho-kinase Is Involved in the Sustained Phosphorylation of Myosin and the Irreversible Platelet Aggregation Induced by PAR1 Activating Peptide
521
Berry, Christopher N.; Lorrain, Janine; Lochot, Sylvette; Delahaye, Monique; Lalé, Alain; Savi, Pierre; Lechaire, Irène; Ferrari, Patrice; Bernat, André; Schaeffer, Paul; Janiak, Philippe; Duval, Nicole; Grosset, Alain; Herbert, Jean-Marc; O’Connor, Stephen E.: Antiplatelet and Antithrombotic Activity of SL65.0472, a Mixed 5-HT1B/5-HT2A Receptor Antagonist
529
Kelleher, Kim L.; Matthaei, Klaus I.: Targeted Disruption of the Mouse Gz-alpha Gene: A Role for Gz in Platelet Function?
533
Cumashi, Albana; Ansuini, Helenia; Celli, Nicola; Blasi, Antonio De; O’Brien, Peter J.; Brass, Lawrence F.; Molino, Marina: Neutrophil Proteases Can Inactivate Human PAR3 and Abolish the Co-receptor Function of PAR3 on Murine Platelets
539
Marciniak, Stanley J.; Jordan, Robert E.; Mascelli, Mary A.: Effect of Ca2+ Chelation on the Platelet Inhibitory Ability of the GPIIb/IIIa Antagonists Abciximab, Eptifibatide and Tirofiban
544
Shariat-Madar, Zia; Mahdi, Fakhri; Schmaier, Alvin: Factor XI Assembly and Activation on Human Umbilical Vein Endothelial Cells in Culture
552
Bonnefoy, Arnaud; Harsfalvi, Jolan; Pfliegler, George; Fauvel-Lafève, Françoise; Legrand, Chantal: The Subendothelium of the HMEC-1 Cell Line Supports Thrombus Formation in the Absence of von Willebrand Factor and Collagen Types I, III and VI

Scientific and Standardization Committee Communication

423
Myers, Daniel D.; Schaub, Robert; Wrobleski, Shirley K.; Londy, Frank J.; Fex, Beverly A.; Chapman, Amy M.; Greenfield, Lazar J.; Wakefield, Thomas W.: P-Selectin Antagonism Causes Dose-dependent Venous Thrombosis Inhibition
441
Xu, Zuojun; Westrick, Randal J.; Shen, YueChun; Eitzman, Daniel T.: Pulmonary Fibrosis Is Increased in Mice Carrying the Factor V Leiden Mutation following Bleomycin Injury
560
White, Gilbert C. II; Rosendaal, Frits; Aledort, Louis M.; Lusher, Jeanne M.; Rothschild, Chantal; Ingerslev, Jørgen: Definitions in Hemophilia

Letters to the Editor

561
Hézard, Nathalie; Metz, Damien; Tassan-Mangina, Sophie; Potron, Gérard; Nguyên, Philippe: Unexpected Flow Cytometric Results with two Small GPIIb/IIIa Blockers: Eptifibatide and Tirofiban
562
Köppel, Herwig; Renner, Wilfried; Seinost, Gerald; Pilger, Ernst: Idiopathic Deep Vein Thrombosis in Siblings with Homozygous Factor V Leiden Mutation
563
Sørensen, Benny; Nielsen, Gitte L.; Ebbesen, Liselotte S.; Ingerslev, Jørgen: Feasibility of LMW Heparin Prophylaxis for Management of Thrombophilia Investigation in Patients on Oral Anticoagulation Therapy
565
Grubb, H.; Lovett, J.; Kingman, H. M.; Copplestone, J. A.; Prentice, A. G.: Nomograms for the Administration of Unfractionated Heparin
566
Ameziane, N.; Lebret, D.; Combe, A.; Aumont, M.-C.; de Prost, D.: No Association between the R2 Factor V Gene and Acute Coronary Events
567
Bestmann, Lukas; Züger, Max; Oldenburg, Johannes; Bühler, Damian; Maly, Friedrich E.: Coagulation Factor IX Propeptide Mutations Causing Coumarin Hypersensitivity: Identification of Female Alanine-10 Valine Heterozygotes
569
Kohler, Hans P.; Ariëns, Robert A. S.; Mansfield, Michael W.; Whitaker, Paul; Grant, Peter J.: Factor XIII Activity and Antigen Levels in Patients with Coronary Artery Disease
570
Takenaga, Makoto; Horinouchi, Kenichi; Shirieda, Katsutoshi; Fukudome, Terumi; Fujimoto, Toshiro: A Novel Nonsense Mutation in the Antithrombin III Gene (Ser365 to Stop) Causing Deep and Mesenteric Venous Thromboses
572
Kazama, Fuminori; Yatomi, Yutaka; Ohmori, Tsukasa; Hosogaya, Shigemi; Ozaki, Yukio: Elevated Expression of Mitochondrial NADH Dehydrogenase Subunit 4/4L Genes in Vascular Endothelial Cells Undergoing Sphingosine-induced Apoptosis
573
Sonoda, Akira; Murata, Mitsuru; Ikeda, Yasuo; Fukuuchi, Yasuo; Watanabe, Kiyoaki: Stroke and Platelet Glycoprotein Ibα Polymorphisms
574
Lowe, Harry C.; Chesterman, Colin N.; Hopkins, Andrew P.; Juergens, Craig P.; Khachigian, Levon M.: Acute Local Release of Fibroblast Growth Factor-2 but not Transforming Growth Factor-β1 following Coronary Stenting